AbbVie's SKYRIZI proves to be a Humira successor with nearly matching sales
Merck & Huma Therapeutics launch their bladder cancer patient support app
EliLilly's growth drivers, Verzenio and Jardiance, face set backs in late-stage clinical trials
Janssen-licensed epilepsy drug fails to reduce seizures in phase 2 trial
Takeda licensed depression drug reduces symptom severity in phase 2 trial
Pfizer's vaccine ranked in first place by physicians
Potential new competitor in the RSV Vaccine space, but GSK's Arexvy maintains market dominance up till now
Pfizer sets up a DTC marketing platform to sell some medicines online
GSK and Genomics collaborate to assess how genetic data can be used in clinical trial design
Novo Nordisk scales Wegovy supply in face of fierce competition from Eli Lilly's Zepbound
Scientists have demonstrated a new RNA-based vaccine strategy that is effective against any strain of a virus, safe for all kinds of people
Researchers identify new enzymes, bringing science closer to developing universal donor blood
Researchers have used cells from rats to restore the sense of smell in mice
Over two-thirds of U.S. physicians now view GenAI as beneficial in healthcare
Two-thirds of top 20 pharmas have banned ChatGPT
%402x.svg){kind=icon}
.png)
%402x.svg){kind=icon}
